PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
32,156,656
Share change
-37,629
Total reported value
$59,321,663
Price per share
$1.84
Number of holders
39
Value change
-$183,839
Number of buys
16
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q4 2014

As of 31 Dec 2014, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,156,656 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, BAILLIE GIFFORD & CO, Consonance Capital Management LP, Camber Capital Management LLC, BlackRock Advisors LLC, DAFNA Capital Management LLC, MENORA MIVTACHIM HOLDINGS LTD., RTW INVESTMENTS, LLC, Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM. This page lists 39 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.